Stefan Costinean

miR-15b/16-2 deletion promotes B-cell malignancies

Carlo M. Croce, Veronica Balatti, Matteo Fassan, 2015, Proceedings of the National Academy of Sciences.

Modulation of mismatch repair and genomic stability by miR-155

Muller Fabbri, Massimo Negrini, Stefano Volinia, 2010, Proceedings of the National Academy of Sciences.

Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice.

Stefano Volinia, Y. Pekarsky, C. Croce, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice.

Stefano Volinia, Rita Mancini, Y. Pekarsky, 2006, Cancer research.

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.

Hansjuerg Alder, Cristian Taccioli, Mario Acunzo, 2009, Cancer cell.

Modulation of miR-155 and miR-125b Levels following Lipopolysaccharide/TNF-α Stimulation and Their Possible Roles in Regulating the Response to Endotoxin Shock1

Muller Fabbri, C. Croce, M. Fabbri, 2007, The Journal of Immunology.

MicroRNAs, the immune system and rheumatic disease

C. Croce, S. Costinean, E. Tili, 2008, Nature Clinical Practice Rheumatology.

MicroRNA Profiles Discriminate among Colon Cancer Metastasis

Stefano Volinia, Gerard J. Nuovo, Hansjuerg Alder, 2014, PloS one.

Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation

Naduparambil K Jacob, Matteo Fassan, Pierluigi Gasparini, 2014, Proceedings of the National Academy of Sciences.

Disruption of miR-29 Leads to Aberrant Differentiation of Smooth Muscle Cells Selectively Associated with Distal Lung Vasculature

Carlo M. Croce, C. Croce, S. Costinean, 2015, PLoS genetics.